Slowly Expanding 18 F-FDG PET-Positive Irregular Opacities in the Lung Due to Diffuse Lymphoid Hyperplasia Preceding Rheumatoid Arthritis

Clin Nucl Med. 2023 Jun 1;48(6):542-544. doi: 10.1097/RLU.0000000000004651. Epub 2023 Apr 24.

Abstract

Pulmonary diffuse lymphoid hyperplasia (DLH), a nonneoplastic lymphoproliferative disorder (LPD), is extremely rare, and no PET/CT findings have been reported for pulmonary DLH. We observed slowly expanding irregular opacities with 18 F-FDG accumulation (SUV max , 3.64) in the right lower lobe of a 51-year-old asymptomatic man. The patient underwent video-assisted thoracoscopic biopsy on suspicion of malignant lesions. Histologically, no neoplastic cells were present, and the lesion was consistent with DLH. Six months later, the patient developed rheumatoid arthritis. DLH should be considered in the differentiation of PET-positive irregular opacities, even in the absence of known immune abnormalities.

MeSH terms

  • Arthritis, Rheumatoid* / complications
  • Arthritis, Rheumatoid* / diagnostic imaging
  • Fluorodeoxyglucose F18
  • Humans
  • Hyperplasia / complications
  • Hyperplasia / diagnostic imaging
  • Lung / diagnostic imaging
  • Lung Diseases* / complications
  • Lung Diseases* / diagnostic imaging
  • Lymphoproliferative Disorders* / complications
  • Lymphoproliferative Disorders* / diagnostic imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18